At the conclusion of this application-based activity, participants will be able to:
  • Examine the interrelationship between diabetes, glycemic control, and cardiovascular disease.
  • Discuss new and emerging cardiovascular outcome trial (CVOT) data for glucose lowering therapies and elucidate the proposed pleiotropic CV effects of these therapies in patients with type 2 diabetes (T2DM).
  • Translate CVOT data to direct patient care by examining patient populations studied in recent CVOTs and potential implications for overall T2DM management strategies in patients with and without cardiovascular disease.